Financhill
Buy
80

CHBAY Quote, Financials, Valuation and Earnings

Last price:
$55.00
Seasonality move :
-1.36%
Day range:
$55.00 - $55.00
52-week range:
$33.94 - $56.18
Dividend yield:
0%
P/E ratio:
14.37x
P/S ratio:
3.39x
P/B ratio:
0.93x
Volume:
--
Avg. volume:
42
1-year change:
45.96%
Market cap:
$7.8B
Revenue:
$2.2B
EPS (TTM):
$3.83

Earnings Data

Next earnings date for CHBAY
Feb 02
2026
Most recent earnings per share
$1.08
Beat by $1.08
(Nov 7/2025)
Consensus Estimate
--
(Nov 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CHBAY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
11/07/2025 Q3 -- $634.2M $1.08 -- --
08/04/2025 Q2 -- $610.4M $1.07 -- --
03/31/2025 Q1 -- $530.2M $0.91 -- --
12/31/2024 Q4 -- $525.9M $0.77 -- --
09/30/2024 Q3 -- $498.2M $0.83 -- --
06/30/2024 Q2 -- $483.3M $0.90 -- --
03/31/2024 Q1 -- $492.1M $0.58 -- --
12/31/2023 Q4 -- $493.8M $0.72 -- --
09/30/2023 Q3 -- $478.4M $0.78 -- --
06/30/2023 Q2 -- $501.7M $0.92 -- --
03/31/2023 Q1 -- $493M $0.61 -- --
12/31/2022 Q4 -- $483.2M $0.65 -- --
09/30/2022 Q3 -- $448.9M $0.90 -- --
06/30/2022 Q2 -- $453.7M $0.88 -- --
03/31/2022 Q1 -- $443.8M $0.53 -- --
12/31/2021 Q4 -- $450M $0.80 -- --
09/30/2021 Q3 -- $489.4M $1.01 -- --
06/30/2021 Q2 -- $497.1M $0.94 -- --
03/31/2021 Q1 -- $500.7M $0.58 -- --
12/31/2020 Q4 -- $517.1M $0.87 -- --
09/30/2020 Q3 -- $470.6M $0.89 -- --
06/30/2020 Q2 -- $487M $0.81 -- --
03/31/2020 Q1 -- $478.4M $0.43 -- --
12/31/2019 Q4 -- $500M $0.81 -- --
09/30/2019 Q3 -- $521.5M $0.84 -- --
06/30/2019 Q2 -- $479.4M $0.85 -- --
03/31/2019 Q1 -- $459.7M $0.53 -- --
12/31/2018 Q4 -- $474.6M $0.70 -- --
09/30/2018 Q3 -- $482.2M $0.83 -- --
06/30/2018 Q2 -- $486.1M $0.87 -- --
03/31/2018 Q1 -- $453.5M $0.43 -- --
12/31/2017 Q4 -- $465.9M $0.84 -- --
09/30/2017 Q3 -- $467.9M $0.82 -- --
06/30/2017 Q2 -- $459.8M $0.96 -- --
03/31/2017 Q1 -- $449.2M $0.48 -- --
12/31/2016 Q4 -- $474.1M $0.78 -- --
09/30/2016 Q3 -- $458.5M $0.71 -- --
06/30/2016 Q2 -- $488.6M $1.05 -- --
03/31/2016 Q1 -- $452.1M $0.51 -- --
12/31/2015 Q4 -- $435.4M $0.65 -- --

The Chiba Bank, Ltd. Earnings Questions

  • How Much did The Chiba Bank, Ltd. Generate in Revenue Last Quarter?

    The Chiba Bank, Ltd. reported $634.2M worth of top line sales in its most recent quarter.

  • Did The Chiba Bank, Ltd. Beat Earnings Last Quarter?

    The Chiba Bank, Ltd. announced earnings per share of $1.08 which represents a beat of analyst forecast a -- per share.

  • Is The Chiba Bank, Ltd. Profitable?

    The Chiba Bank, Ltd. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for The Chiba Bank, Ltd. EPS Next Year?

    The Chiba Bank, Ltd.'s earnings are forecast to grow from $3.42 per share to -- per share next year representing an increase of --.

  • When is The Chiba Bank, Ltd.'s Earnings Date?

    The Chiba Bank, Ltd.'s next earnings date is February 2, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock